Search results for "Expert opinion"

showing 10 items of 30 documents

Mark-recapture estimation of mortality and migration rates for sea trout (Salmo trutta) in the northern Baltic sea

2016

Knowledge of current fishing mortality rates is an important prerequisite for formulating management plans for the recovery of threatened stocks. We present a method for estimating migration and fishing mortality rates for anadromous fishes that combines tag return data from commercial and recreational fisheries with expert opinion in a Bayesian framework. By integrating diverse sources of information and allowing for missing data, this approach may be particularly applicable in data-limited situations.Wild populations of anadromous sea trout (Salmo trutta) in the northern Baltic Sea have undergone severe declines, with the loss of many populations. The contribution of fisheries to this dec…

0106 biological sciencesBaltic SeaAquatic ScienceOceanography010603 evolutionary biology01 natural sciencesMark and recaptureRecreational fishingSea trout14. Life underwaterSalmoEcology Evolution Behavior and SystematicsEstimationta112sea troutEcologybiology010604 marine biology & hydrobiologybiology.organism_classificationexpert opinionFisheryOceanographyGeographyBaltic seaExpert opinionrecreational fisheriesta1181mark-recaptureICES Journal of Marine Science
researchProduct

A preliminary approach for modelling the effects of cropping systems on the dynamics of broomrape ( Phelipanche ramosa) in interaction with the non-p…

2011

International audience; The current decrease in herbicide use may increase and diversify weed flora in crops as well as companion bioagressors spreading via weeds. Among these bioagressors is Phelipanche ramosa (L.) Pomel, a parastic plant which is very harmful on oilseed rape. The objective of the present work was to develop a new model (called PheraSys) of the effects of cropping systems on parasite dynamics, in interaction with non-parasitic weed hosts. The structure of this first model version was based on models developed for other parasitic plants and on FlorSys which quantifies the effects of cropping systems on non-parasitic weed flora. PheraSys was parametrized with preliminary val…

0106 biological sciencesFloraoilseed rapeParasitic plant[SDV]Life Sciences [q-bio]lcsh:TP670-699cropping system01 natural sciencesBiochemistryBrassica napus L[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BV] Life Sciences [q-bio]/Vegetal BiologyCropping systemparasitic plantmodelbiologyHost (biology)broomrapePHELIPANCHE RAMOSA04 agricultural and veterinary sciencesbiology.organism_classification[SDV] Life Sciences [q-bio]Phelipanche ramosaAgronomyExpert opinion040103 agronomy & agriculture0401 agriculture forestry and fisherieslcsh:Oils fats and waxesWeedCroppingPhelipanche ramosa L PomelPhelipanche ramosa (L.) Pomel010606 plant biology & botanyFood Scienceweed
researchProduct

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

2018

Phage therapy is increasingly put forward as a "new" potential tool in the fight against antibiotic resistant infections. During the "Centennial Celebration of Bacteriophage Research" conference in Tbilisi, Georgia on 26-29 June 2017, an international group of phage researchers committed to elaborate an expert opinion on three contentious phage therapy related issues that are hampering clinical progress in the field of phage therapy. This paper explores and discusses bacterial phage resistance, phage training and the presence of prophages in bacterial production strains while reviewing relevant research findings and experiences. Our purpose is to inform phage therapy stakeholders such as po…

0301 basic medicinephage therapyPhage therapyprophagemedicine.medical_treatmentviruses030106 microbiologylcsh:QR1-502Resistance (psychoanalysis)adaptationlcsh:MicrobiologyBacteriophageresistance03 medical and health sciencesAntibiotic resistanceVirologyPolitical sciencemedicineBacteriophageProphageComputingMilieux_MISCELLANEOUSbiologybusiness.industryConference ReportregulationPublic relationsResearch findingsbiology.organism_classification[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology3. Good healthInfectious DiseasesExpert opinionproductionbusinessViruses
researchProduct

Ambulatory Glucose Profile Applied to Flash Glucose Monitoring in Real Life: An Expert Opinion.

2016

The clinical benefits of real time continuous glucose monitoring (rtCGM) use have been well demonstrated in both CSII- and MDI-treated individuals in large clinical trials. However, recommendations for patient use of rtCGM in everyday life situations are lacking. This article provides guidance to clinicians and patients with type 1 diabetes (T1D) in effective use of rtCGM data, including glucose rate of change (ROC) arrows, for insulin dosing adjustments and other treatment decisions. The recommendations presented here are based on our own clinical experiences as endocrinologists, our personal experiences living with T1D using rtCGM, and findings from a recent survey of T1D patients who hav…

Blood Glucosemedicine.medical_specialtymultiple daily insulin injectionstype 1 diabetesEndocrinology Diabetes and MetabolismMonitoring ambulatoryBiomedical Engineeringflash glucose monitoringrate of changeMonitoring Ambulatory030209 endocrinology & metabolismBioengineeringglucose-monitoring systemMDI03 medical and health sciencesFlash (photography)0302 clinical medicineDiabetes mellitusBlood Glucose Self-MonitoringmedicineInternal MedicineIn real lifeambulatory glucose profile; diabetes; flash glucose monitoring; glucose-monitoring systems; glycemic control030212 general & internal medicineglucose-monitoring systemsIntensive care medicineambulatory glucose profileExpert TestimonyReview Articlesdiabetesbusiness.industryMedicine (all)Blood Glucose Self-MonitoringCSIImedicine.diseaseDiabetes Mellitus Type 1GlucosediabeteExpert opinioninsulin pumpAmbulatoryglucose profileglycemic controlcontinuous glucose monitoringMedical emergencybusinessJournal of diabetes science and technology
researchProduct

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, B…

2011

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the ne…

Continuous infusionComputer assisted radiotherapyFolic acidFluorodeoxyglucose f 18Gimeracil plus oteracil potassium plus tegafurInfection controlIntensity modulated radiation therapyDocetaxelCancer stagingMetastatic gastric cancerRisk FactorsPrevalenceDrug fatalityOverall survivalNeoplasm MetastasisPriority journalddc:616Conference paperdigestive oral and skin physiologyFolinic acidHematologyPrognosisOxaliplatinNuclear magnetic resonance imagingBevacizumabSurvival RateOncologyCyanocobalaminPractice Guidelines as TopicDrug dose reductionFluorouracilEsophageal adenocarcinomaHumanPositron emission tomographymedicine.medical_specialtyNeutropeniaStomach cancerStomach neoplasmsMEDLINESide effectStomach adenocarcinomaPatient careIrinotecanHelicobacter infectionPrimary tumorEndoscopic echographyAdvanced cancerEndoscopic mucosal resectionComputer assisted tomographyStomach Neoplasms/*diagnosis/pathology/*therapymedicineHumansGenetic Predisposition to DiseaseGastrointestinal cancerPhase 3 clinical trial (topic)Intensive care medicineSurvival ratePlaceboCapecitabineEpirubicinCa 19-9 antigenStomach Neoplasms/diagnosis/pathology/therapyHelicobacter pyloribusiness.industryCancerTrastuzumabCardiovascular riskmedicine.diseaseCancer susceptibilitydigestive system diseasesSurgeryClinical trialMetastasis potentialExpert opinionMeta analysis (topic)Cancer adjuvant therapyCarcinoembryonic antigenLower esophagus sphincterCisplatinCaloric intakebusinessCancer incidenceRegional differencesAnnals of Oncology
researchProduct

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

2019

1. Preamble : Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD) [1]. Increased levels of low density lipoprotein cholesterol (LDL-C) are associated with an increased risk of coronary heart disease (CHD) and many clinical trials have shown that reducing LDL-C levels significantly reduced the CHD and CVD risk [[2], [3], [4], [5]]. Thus LDL-C-lowering is the main approach for the management of cardiovascular disease. Current guidelines suggest LDL-C levels targets based on the individual CV risk; such targets can be achieved by several means, which include both lifestyle changes and pharmacological approaches [6], with statins being the cornerstone …

Gastrointestinal Diseases[SDV]Life Sciences [q-bio]Hypercholesterolemia/Self Medication030204 cardiovascular system & hematologyPharmacology03 medical and health sciencesFood-Drug Interactions0302 clinical medicinePlasma cholesterolBiotransformationDouble-Blind MethodChinese traditionalInternal MedicineRed yeast riceMedicineCytochrome P-450 CYP3AHumansMulticenter Studies as TopicProdrugs030212 general & internal medicineLovastatinMusculoskeletal DiseasesMedicine Chinese TraditionalExpert TestimonyComputingMilieux_MISCELLANEOUSBiotransformationRandomized Controlled Trials as TopicBiological ProductsClinical Trials as TopicMolecular StructureRyanodine receptorbusiness.industryGeneral Medicine3. Good healthCholesterol blood[SDV] Life Sciences [q-bio]CholesterolCardiovascular DiseasesExpert opinionDietary Supplementslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular Medicinebusiness
researchProduct

Raynaud-Phänomen bei einer beruflichen Vibrationsbelastung

2013

Anamnese und klinischer Befund: Eine 34-jahrige Steinmetzin wurde mit der Fragestellung eines vibrationsbedingten vasospastischen Syndroms (VVS) begutachtet. Ihre Hande waren langjahrig gegenuber den hochfrequenten Schwingungen verschiedener Werkzeuge exponiert gewesen. Die Patientin berichtete uber Weisfingeranfalle an den Langfingern, die bei Kalte aufgetreten waren. Der korperliche Befund war zu diesem Zeitpunkt regelrecht. Untersuchungen: Der Kaltwasserprovokationstest zeigte an den Langfingern der rechten Hand eine leicht verzogerte Wiedererwarmung; die Kapillarmikroskopie der Finger war regelrecht. Diagnose und Verlauf: Das leichtgradige Raynaud-Phanomen wurde als Berufskrankheit der …

Gynecologymedicine.medical_specialtybusiness.industryExpert opinionDisease progressionRaynaud phanomenMedicineGeneral MedicineVibration exposurebusinessDMW - Deutsche Medizinische Wochenschrift
researchProduct

Hsp60 chaperonopathies and chaperonotherapy: targets and agents

2014

Hsp60 (Cpn60) assembles into a tetradecamer that interacts with the co-chaperonin Hsp10 (Cpn10) to assist client polypeptides to fold, but it also has other roles, including participation in pathogenic mechanisms.Hsp60 chaperonopathies are pathological conditions, inherited or acquired, in which the chaperone plays a determinant etiologic-pathogenic role. These diseases justify selection of Hsp60 as a target for developing agents that interfere with its pathogenic effects. We provide information on how to proceed.The information available encourages the development of ways to improve Hsp60 activity (positive chaperonotherapy) when deficient or to block it (negative chaperonotherapy) when pa…

InflammationPharmacologyanimal structuresChaperonin 60biologyProtein ConformationfungiClinical BiochemistryChaperonin 60BioinformaticsAutoimmune Diseasesautoimmunity cancer carboranylphenoxyacetanilide chaperonopathies chaperonotherapy chemical compounds Cpn60 electrophilic compounds epolactaene functional domain GroEL Hsp60 inflammation mizoribine structural domainNeoplasmsChaperone (protein)Expert opinionDrug DiscoveryImmunologybiology.proteinAnimalsHumansMolecular MedicineHSP60Cytokine formationA determinantExpert Opinion on Therapeutic Targets
researchProduct

European expert opinion on the management of invasive candidiasis in adults

2011

Item does not contain fulltext This report discusses the present status of antifungal therapy and treatment options for candidaemia, considered by experts in the field in Europe. A conference of 26 experts from 13 European countries was held to discuss strategies for the treatment and prevention of invasive candidiasis, with the aim of providing a review on optimal management strategies. Published and unpublished comparative trials on antifungal therapy were analysed and discussed. Commonly asked questions about the management of candidaemia were selected, and possible responses to these questions were discussed. Panellists were then asked to respond to each question by using a touchpad ans…

Invasive mycoses and compromised host Translational research [N4i 2]AdultMicrobiology (medical)medicine.medical_specialtyAntifungal Agentsmedicine.medical_treatmentPlacebo-controlled studyMEDLINEInvasive mycoses and compromised host Infection and autoimmunity [N4i 2]MicrobiologyMedicineHumanscandidaemiaCandidiasis InvasiveguidelinesIntensive care medicineWatchful Waitingtherapybusiness.industryTreatment optionsPathogenesis and modulation of inflammation Infection and autoimmunity [N4i 1]General MedicineInvasive candidiasisComparative trialAntibiotic Prophylaxismedicine.diseaseOptimal managementEuropeIntensive Care UnitsInfectious DiseasesconsensusExpert opinioncandidabusinessWatchful waitingClinical Microbiology and Infection
researchProduct

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.

2010

It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.

Liver CirrhosisANTIVIRAL TREATMENTHuman immunodeficiency virus (HIV)HIV InfectionsHepacivirusANTIVIRAL THERAPY; PEGYLATED INTERFERON-ALPHA-2B; LIVER-TRANSPLANTATION; PEGINTERFERON ALPHA-2A; HIV-INFECTED PATIENTS; VIRUS-COINFECTED PATIENTS; RAPID VIROLOGICAL RESPONSEAntiviral therapymedicine.disease_causeGastroenterologyPolyethylene GlycolsHBVguidelinesAcute hepatitisChronic hepatitisSettore MED/12 - Gastroenterologialiver transplantationGastroenterologyAntiviral therapyHepatitis CVIRUS-COINFECTED PATIENTSLIVER-TRANSPLANTATIONHepatitis CRecombinant Proteinsacute hepatitis; antiviral therapy; chronic hepatitis; cirrhosis; elderly patients; hbv; hcv; hdv; hiv; liver transplantationCLINICAL PRACTICE GUIDELINESCirrhosisHCVDrug Therapy CombinationAntiviral therapy Acute hepatitis Chronic hepatitisCirrhosis Elderly patients HBV HCV HDV HIV Liver transplantationElderly patientAcute hepatitiAcute hepatitismedicine.medical_specialtyGenotypePEGINTERFERON ALPHA-2AAlpha interferonHIV-INFECTED PATIENTSInterferon alpha-2CHRONIC HEPATITIS CAntiviral AgentsHepatitis B ChronicChronic hepatitisInternal medicineHDVDrug Resistance ViralRibavirinmedicineHumansPEGYLATED INTERFERON-ALPHA-2BCirrhosiHepatologybusiness.industrySettore MED/09 - MEDICINA INTERNAInterferon-alphaHIVHepatitis C Chronicmedicine.diseaseElderly patientsFamily medicineExpert opinionAntiviral therapy; Acute hepatitis; Chronic hepatitis; Cirrhosis; Elderly patients; HBV; HCV; HDV; HIV; liver transplantationChronic hepatitiRAPID VIROLOGICAL RESPONSEbusinessCHRONIC HEPATITIS C; ANTIVIRAL TREATMENT; CLINICAL PRACTICE GUIDELINES
researchProduct